Clinical Trials Directory

Trials / Unknown

UnknownNCT04417010

To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation

A Prospective Study to Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation

Status
Unknown
Phase
—
Study type
Observational
Enrollment
163 (estimated)
Sponsor
Peking University Cancer Hospital & Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
—

Summary

To investigate the clinical effect of radiofrequency ablation on colorectal cancer liver metastases with different KRAS gene status

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablationBoth groups of patients underwent radiofrequency ablation

Timeline

Start date
2020-06-01
Primary completion
2023-05-31
Completion
2023-05-31
First posted
2020-06-04
Last updated
2020-06-09

Source: ClinicalTrials.gov record NCT04417010. Inclusion in this directory is not an endorsement.